Status:
COMPLETED
Early Life Interventions for Childhood Growth and Development In Tanzania
Lead Sponsor:
Haydom Lutheran Hospital
Collaborating Sponsors:
University of Virginia
Bill and Melinda Gates Foundation
Conditions:
Malnutrition
Stunting
Eligibility:
All Genders
Up to 14 years
Phase:
PHASE2
PHASE3
Brief Summary
This study aims to assess growth and cognitive effects of treatment with azithromycin and nitazoxanide and/or nicotinamide (vitamin B3) supplementation nicotinamide.
Detailed Description
Children living in rural sub-Saharan Africa experience massive challenges to child thriving, with poor linear growth and delays in child development. In a cohort of 211 children living in the rural Ha...
Eligibility Criteria
Inclusion
- Maternal age ≥18
- Infant ≤ 14 days
Exclusion
- Maternal inability to adhere to protocol
- Multiple gestation
- Severe illness (significant birth defect, hospitalization, severe neonatal illness)
- Birth weight \<1500 g
- Lack of breastfeeding at enrollment (and lack of intention to continue breastfeeding at time of enrollment).
Key Trial Info
Start Date :
September 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2020
Estimated Enrollment :
1188 Patients enrolled
Trial Details
Trial ID
NCT03268902
Start Date
September 5 2017
End Date
March 26 2020
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haydom Lutheran Hospital
Haydom, Manyara Region, Tanzania